Dokument: The Clinical Impact of FAPI PET Imaging: HCC, CCC, CUP & Peritoneal Carcinoma
| Titel: | The Clinical Impact of FAPI PET Imaging: HCC, CCC, CUP & Peritoneal Carcinoma | |||||||
| URL für Lesezeichen: | https://docserv.uni-duesseldorf.de/servlets/DocumentServlet?id=70786 | |||||||
| URN (NBN): | urn:nbn:de:hbz:061-20250917-120143-6 | |||||||
| Kollektion: | Publikationen | |||||||
| Sprache: | Englisch | |||||||
| Dokumententyp: | Wissenschaftliche Texte » Artikel, Aufsatz | |||||||
| Medientyp: | Text | |||||||
| Autoren: | Novruzov, Emil [Autor] Mamlins, Eduards [Autor] Mori, Yuriko [Autor] Cardinale, Jens [Autor] Giesel, Frederik L. [Autor] | |||||||
| Dateien: |
| |||||||
| Beschreibung: | In recent years, FAP-targeted imaging has emerged as a highly-promising modality as a pan-cancer agent. Until now, several studies and review articles have focused on efficacy of FAPI imaging in epithelial malignancies with a high global incidence and prevalence such as lung cancer or GI-tumors. This work sought to shed light on diagnostic performance and clinical impact of FAPI imaging in rather low-incidence tumor-entities, which are nevertheless characterized by a poor outcome. | |||||||
| Rechtliche Vermerke: | Originalveröffentlichung:
Novruzov, E., Mamlins, E., Mori, Y., Cardinale, J., & Giesel, F. L. (2025). The Clinical Impact of FAPI PET Imaging: HCC, CCC, CUP & Peritoneal Carcinoma. Seminars in Nuclear Medicine , 55(5), 724–733. https://doi.org/10.1053/j.semnuclmed.2025.07.001 | |||||||
| Lizenz: |  Dieses Werk ist lizenziert unter einer Creative Commons Namensnennung 4.0 International Lizenz | |||||||
| Fachbereich / Einrichtung: | Medizinische Fakultät | |||||||
| Dokument erstellt am: | 17.09.2025 | |||||||
| Dateien geändert am: | 17.09.2025 |
